Beijing Hotgen Biotech Co., Ltd. (688068.SS) SHH

182.28

+4.96(+2.80%)

Updated at October 20 09:25AM

Currency In CNY

Valuation

Market Cap5.71B
Enterprise Value5.44B
P/E Ratio-75.55
PEG Ratio-3.05
Price/Sales Ratio36.26
Price/Book Ratio5.65
Enterprise/Revenue35.98
Enterprise/EBITDA-81.24

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.47
Operating Margin-0.47

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.07

Income Statement

Revenue510.9M
Revenue/Share5.12
Gross Profit253.72M
EBITDA-69.84M
Net Income-191M
Diluted EPS-2.07

Balance Sheet

Total Cash582.62M
Total Cash/Share6.4
Total Debt50.14M
Total Debt/Equity0.02
Current Ratio4.5
Book Value Per Share32.22

Price History

52-Week Change537.34
52-Week High262.22
52-Week Low27.88
Moving Average 50 Days192.88
Moving Average 200 Days136.98

Statistics

Average Volume2.92M
Shares Outstanding92.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.03
Last Split Factor37:25
Last Split DateJune 16, 2022